Gilead Sciences, Inc’s recent filing unveils that its Chief Commercial Officer Mercier Johanna unloaded Company’s shares for reported $0.33 million
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Gilead Sciences, Inc’s recent filing unveils that its Chairman & CEO O’Day Daniel Patrick unloaded Company’s shares for reported $1.1
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Gilead Sciences,
Gilead Sciences, Inc’s recent filing unveils that its Chairman & CEO O’Day Daniel Patrick unloaded Company’s shares for reported $1.1
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Gilead Sciences, Inc’s filing revealed that its Officer DANIEL O’DAY acquired Company’s shares for reported $1.1 million on Jun 30
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Gilead Sciences, Inc’s recent filing unveils that its Chief Financial Officer Dickinson Andrew D unloaded Company’s shares for reported $0.28